Asian External Beam Radiotherapy Devices Market Research Report
- Report Code: EX 1003
- Publish Date: Upcoming
The Asian external beam radiotherapy devices market, mainly driven by the rapidly changing cancer treatment technology and the growing number of cancer patients, was valued at $699.2 million in 2013, and is expected to be $919.6 million by 2018, at a CAGR of 5.6%. The external beam radiotherapy market is the largest segment of the radiotherapy devices market. The high energy linear accelerators segment commands the largest share of 80%, in the Asian external beam radiotherapy market.
The report analyzes the market of devices by 3 segments, such as compact advanced radiotherapy systems, proton radiotherapy systems and electron emitting high energy linear accelerators (LINAC). All these segments experienced a positive growth till 2013, with an increase in cancer patient pool, and the increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $575.8 million and $90.8 million respectively, the high energy linear accelerators (LINAC) and compact advance radiotherapy system segments have been contributing 82.3% and 13% in the total radiotherapy devices market.
In Asia (India, China, and Japan) the rising rates of cancer population have been driving the market growth. The market growth is significantly higher in North America because it is always inclined to the newer techniques, while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies.
The report also provides an extensive competitive landscaping of the leading companies operating in the external beam radiotherapy devices market. The main companies operating in the market and extensively covered in this report are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, Covidien, Protom international, Inc., Mevion Medical Systems, Inc. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) products (segment-wise)
- Product matrix, which gives a detailed comparison of the product portfolios of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data:
- Country-specific prevalence of prostate cancer, breast & female genital organs cancers, lung & pleura cancers, head & neck cancers, colorectal cancer, spine cancer, and brain cancer
- Country-specific patient pool of prostate cancer, breast & female genital organs cancers, lung & pleura cancers, head & neck cancers, colorectal cancer, spine cancer, and brain cancer
- Disease progression (pattern analysis)
Procedure Volume Data:
- Number of prostate cancer, brain cancer, lung, and head & neck cancers surgeries performed annually in each country, tracked till sub-segment level
Surgeons/Physicians Perception Analysis:
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/ Product Perception Matrix:
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends:
- Cost analysis of radiotherapy devices in various countries
- Prostate cancer, brain cancer, lung, and head & neck cancers procedural investment in major countries
Competitive Intelligence:
- The company share analysis of the top players of the market
- The crucial developments and strategies that companies inculcate in their portfolio
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Radiotherapy Devices Market The North American Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1878.7 million in 2013 and expected to be $2072.9 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European Radiotherapy Devices Market The European Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $915.4 million in 2013 and expected to be $1028.1 million by 2018, growing at a CAGR of 2.3%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian Radiotherapy Devices Market The Asian Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $847.8 million in 2013 and expected to be $1107.8 million by 2018, growing at a CAGR of 5.5%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
